Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.
But not every company with momentum is a long-term winner, and plenty of investors have lost money betting on short-term fads. All that said, here are three overhyped stocks that may correct and some you should consider instead.
Solventum (SOLV)
One-Month Return: +12.6%
Founded in 1985, Solventum (NYSE: SOLV) develops, manufactures, and commercializes a portfolio of healthcare products and services addressing critical customer and therapeutic patient needs.
Why Do We Think SOLV Will Underperform?
- Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth
- Sales are projected to be flat over the next 12 months and imply weak demand
- 30.8 percentage point decline in its free cash flow margin over the last five years reflects the company’s increased investments to defend its market position
Solventum is trading at $86.85 per share, or 13.2x forward P/E. Check out our free in-depth research report to learn more about why SOLV doesn’t pass our bar.
Addus HomeCare (ADUS)
One-Month Return: +16.1%
Serving approximately 66,000 clients across 22 states with a focus on "dual eligible" Medicare and Medicaid beneficiaries, Addus HomeCare (NASDAQ: ADUS) provides in-home personal care, hospice, and home health services to elderly, chronically ill, and disabled individuals.
Why Are We Wary of ADUS?
- Smaller revenue base of $1.45 billion means it hasn’t achieved the economies of scale that some industry juggernauts enjoy
- ROIC hasn’t moved, making investors question whether its recent investments can increase profitability
Addus HomeCare’s stock price of $116.65 implies a valuation ratio of 16.9x forward P/E. If you’re considering ADUS for your portfolio, see our FREE research report to learn more.
Hope Bancorp (HOPE)
One-Month Return: +2.6%
With roots in serving Korean-American communities and now expanded to a multi-ethnic clientele across 12 states, Hope Bancorp (NASDAQ: HOPE) operates Bank of Hope, providing commercial and retail banking services with a focus on serving multi-ethnic communities across the United States.
Why Should You Sell HOPE?
- Loans are facing end-market challenges during this cycle, as seen in its flat net interest income over the last five years
- Performance over the past five years shows its incremental sales were much less profitable, as its earnings per share fell by 4.1% annually
- Products and services are facing profitability challenges during this cycle, as seen in its flat tangible book value per share over the last two years
At $14.03 per share, Hope Bancorp trades at 0.8x forward P/B. Dive into our free research report to see why there are better opportunities than HOPE.
High-Quality Stocks for All Market Conditions
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.
